Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on November 10th, 2017% Drug maker Sanofi is licensing a drug candidate from Principia Biopharma Inc. designed to treat multiple sclerosis, an autoimmune condition affecting the brain and nervous system. . . . → Read More: Sanofi Acquires Multiple Sclerosis Drug in $800M Deal
By Alan, on November 9th, 2017% Online resources are still a relatively new concept in the grand scheme of things, especially for a modern law firm. . . . → Read More: Psychology In Law: How Important Is An Online Presence For A Modern Law Firm?
By Alan, on November 9th, 2017% Memorial Sloan Kettering Cancer Center in New York is collaborating with health care analytics company Cota Inc. to offer more precise care strategies for patients. . . . → Read More: Cancer Center, Analytics Company Partner on Precision Care
By Alan, on November 8th, 2017% An initiative joining most major health care stakeholders is developing models to calculate the value of medical treatments, with a process described as open and transparent. . . . → Read More: Open-Source Model Devised to Value Medical Technologies
By Alan, on November 8th, 2017% Findings from a clinical trial show the use of virtual reality can prevent much of the pain and anxiety in children when drawing blood for tests. . . . → Read More: Virtual Reality Shown to Reduce Blood Draw Pain in Kids
By Alan, on November 8th, 2017% Here are a few things that you need to think about in order to make sure that you’re ready to do business in the digital world. . . . → Read More: Are You Ready To Do Business In The Digital World?
By Alan, on November 7th, 2017% An organization is being formed to adopt performance-based financing and precision medicine to accelerate research and development on pancreatitis. . . . → Read More: New Finance, Development Model for Pancreatic Disease
By Alan, on November 7th, 2017% A new type of treatment for depression that works differently from most other anti-depressive drugs was shown in lab mice to reduce depression-like behaviors. . . . → Read More: New Drug Shown to Reduce Depressive Behaviors
By Alan, on November 6th, 2017% The U.S. Food and Drug Administration is proposing new review requirements for genetic tests of health risks that providers market directly to consumers. . . . → Read More: FDA Sets Genetic Health Test Review Process
By Alan, on November 6th, 2017% Results from a small-scale clinical trial indicate treatments with plasma infusions from young donors are safe for patients and may improve functional abilities. . . . → Read More: Plasma Infusions to Treat Alzheimer’s Shown Safe
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|